Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities    
Net income (loss) $ 24,410 $ 13,708
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision for loss on receivables 648 0
Depreciation and amortization 895 1,136
Amortization of deferred financing costs 2,096 1,673
Equity-based compensation 3,548 3,578
Equity method investments 8,914 2,024
Non-cash gain on securitization (14,302) (6,610)
Gain on sale of receivables and investments 9,397 0
Changes in accounts payable and accrued expenses (11,291) (9,285)
Other (12,660) (2,771)
Net cash provided by (used in) operating activities 11,655 3,453
Cash flows from investing activities    
Equity method investments (140,877) (10,448)
Equity method investment distributions received 50,143 20,530
Purchases of and investments in receivables (29,671) (22,430)
Principal collections from receivables 38,276 21,345
Proceeds from sales of receivables 8,035 26,919
Purchases of investments (15,937) (6,809)
Principal collections from investments 1,048 1,325
Proceeds from sales of investments and securitization assets 42,920 0
Funding of escrow accounts (712) (11,869)
Withdrawal from escrow accounts 1,273 7,945
Other 35 69
Net cash provided by (used in) investing activities (45,467) 26,577
Cash flows from financing activities    
Proceeds from credit facilities 126,000 26,500
Principal payments on credit facilities (4,347) (1,925)
Proceeds from issuance of non-recourse debt 15,938 13,923
Principal payments on non-recourse debt (83,488) (35,180)
Net proceeds of common stock issuances 114,760 46,388
Payments of dividends and distributions (24,363) (20,518)
Withholdings on employee share vesting (15,968) (6,422)
Other (990) (6,008)
Net cash provided by (used in) financing activities 127,542 16,758
Increase (decrease) in cash, cash equivalents, and restricted cash 93,730 46,788
Cash, cash equivalents, and restricted cash at beginning of period 106,586 59,353
Cash, cash equivalents, and restricted cash at end of period 200,316 106,141
Interest paid 25,436 14,882
Non-cash changes in residual assets (investing activity) $ (14,302) $ (6,636)